Allied Market Research
Loading...
0
New
New
2021
Organ-tumor-on-a-chip Market

Organ-Tumor-on-a-Chip Market by Type (Lung Tumor-on-a-chip, Bone Marrow Tumor-on-a-chip, Brain Tumor-on-a-chip, Breast Tumor-on-a-chip, Urinary System Tumor-on-a-chip, Intestine Tumor-on-a-chip, and Liver Tumor-on-a-chip): Global Opportunity Analysis and Industry Forecast, 2021–2030

A04570
Pages: 150
Nov 2021 | 4972 Views
   
Author(s) : Kishor Sherkar, Shubham Choudante , Onkar Sumant
Tables: 56
Charts: 20
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Organ-tumor-on-a-chip Market

Request Now !

Organ-Tumor-on-a-Chip Market Statistics

The global organ-tumor-on-a-chip market size was valued at $5,937.27 thousand in 2020, and is projected to reach $117,471.41 thousand by 2030, registering a CAGR of 34.3% from 2021 to 2030. Cancer is one of the leading causes of death, despite enormous efforts to explore cancer biology and develop anticancer therapies. The main challenges in cancer research are establishing an efficient tumor microenvironment in vitro and exploring efficient means for screening anticancer drugs to reveal the nature of cancer and develop treatments. Tumor-on-a-chip is a miniature cell culture device that simulates tumor cell tissue structure and functional units in vitro. Tumor-on-a-chip can be used to simulate tumor growth and expansion, angiogenesis, and progression from early to advanced lesions involving epithelial–mesenchymal transition (EMT), tumor cell invasion and metastasis.

The COVID-19 outbreak has impacted the global organ-tumor-on-a-chip negatively. The continued COVID-19 pandemic adversely impacted various aspects of several companies’ operations, the manufacturing and supply chain, sales and marketing, clinical trial operations of potential strategic partners, and the R&D activities and development of the pipeline products.

Organ-on-a-chip systems are based on the use of microfluidics to construct tissue models. Tumor-on-a-chip systems have emerged by using cancer-derived cells and related extracellular matrix (ECMs) in tissue-specific structures to replace healthy cells. Therefore, the main processing technology of tumor-on-a-chip systems is the same as that of organ-on-a-chip systems.

Organ-tumor-on-a-chip-Market-2021-2030

Get more information on this report : Request Sample Pages

There are several key elements in fabricating an integrated organ-on-a-chip, including a microfluidic system, 2D/3D microtissue culturing, stimulus-loading components, and sensors for monitoring and readout of the results. The emerging tumor-on-a-chip platforms integrating 3D cell culture, microfluidic technology, and tissue engineering have successfully mimicked the pivotal structural and functional characteristics of the in vivo tumor microenvironment.

A variety of techniques have been adopted to fabricate tumor-on-a-chip devices, among which the most widely employed are photolithography, replica molding, soft lithography, microcontact printing and bioprinting technology. With the development of materials and manufacturing techniques, such as microfluidics and microprinting, combined with stem cell technology, 3D human tissue-like models known as organoids and spheroids are generated. They can be used in human development research, disease progression, and treatment as well as to develop personalized drug methods. Organoids are 3D cell culture models that can self-organize into complex organ-like tissues. To create biomimetic 3D tumor models that better encapsulate pathologic processes, several important factors in the tumor microenvironment must be considered, including oxygen tension, which is a key regulator of cellular behavior. In contrast to the tumor growth microenvironment in vivo, tumor models in vitro are usually under atmospheric oxygen conditions, which are not representative of the conditions in vivo.

A variety of human-derived in vitro tumor-on-a-chip models have been developed for studying various characteristics associated with tumor progression, such as growth, angiogenesis, metastasis, and drug response. By combining advanced microfabrication techniques, such as photolithography, soft lithography and bioprinting, with microfluidic and tissue engineering techniques, tumor chips can ideally reproduce specific key aspects of the tumor microenvironment, such as biochemical gradients and niche factors, dynamic cell–cell and cell–matrix interactions, and complex tissue structures comprised of tumor and stromal cells. Since the tumor-on-a-chip system is usually composed of cells from a single organ, its recombination ability is limited. To solve this problem, researchers developed multiorgan-on-a-chip systems to evaluate the efficacy and off-target toxicity of anticancer therapeutics.

Impact Of Covid-19 On Organ-tumor-on-a-chip Market (Pre And Post Analysis)

The COVID-19 outbreak has impacted the global organ-tumor-on-a-chip market negatively. The COVID-19 pandemic has resulted in government authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter-in-place or stay-at-home orders, and business shutdowns, which impacted reliable supply of sufficient human cells or a supply at cost-effective prices, which harmed the business results of operations The extent to which COVID-19 will impact the future developments is highly uncertain and cannot be predicted with confidence, including the rise of vaccine-resistant variants, duration of the outbreak, travel bans, restrictions, quarantines, shelter-in-place or stay-at-home orders, and business shutdowns.

Global Organ-tumor-on-a-chip Market Segmentation

The organ-tumor-on-a-chip market is segmented on the basis of type, and region. By type, the market is segmented into lung tumor-on-a-chip, bone marrow tumor-on-a-chip, brain tumor-on-a-chip, breast tumor-on-a-chip, urinary system tumor-on-a-chip, intestine tumor-on-a-chip, and liver tumor-on-a-chip. 

Region wise, the organ-tumor-on-a-chip market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment Review

By type, the lung tumor-on-a-chip segment was the highest revenue generator in 2020, and is anticipated to continue this trend in the future, owing to rising prevalence in lung cancer cases.

Organ-Tumor-on-a-Chip Market
By Type

Your browser does not support the canvas element.

Lung Tumor-on-a-chip segment holds a dominant position in 2020

Get more information on this report : Request Sample Pages

By region, North America accounted for the largest organ-tumor-on-a-chip market share in 2020 and is expected to retain its dominance throughout the forecast period, owing to rise in demand for organ-tumor-on-chips in drug screening, especially in the U.S., increase in number of key market players, and research centers in the region.

The major companies profiled in this report include Axosim Technologies LLC, Beonchip S. L., BioIVT LLC, Emulate Inc., InSphero AG, Mimetas B.V., Nortis, Inc., and Organovo Holdings, Inc.

Organ-Tumor-on-a-Chip Market
By Region

2030
Europe 
North America
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 36.90% during 2021-2030.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global organ-tumor-on-a-chip market to identify the prevailing opportunities.
  • This study presents the competitive landscape of the global organ-tumor-on-a-chip market to predict the competitive environment across geographies.
  • Comprehensive analysis of factors that drive and restrict the organ-tumor-on-a-chip market growth is provided.
  • Region- & country-wise analysis is provided to understand the organ-tumor-on-a-chip market trends and dynamics

Key Market Segments

  • By Type
    • Lung Tumor-on-a-chip
    • Bone Marrow Tumor-on-a-chip
    • Brain Tumor-on-a-chip
    • Breast Tumor-on-a-chip
    • Urinary System Tumor-on-a-chip
    • Intestine Tumor-on-a-chip
    • Liver Tumor-on-a-chip
  • BY REGION
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA
  • By Key Market Players
    • Axosim Technologies LLC
    • Beonchip S. L.
    • BioIVT LLC
    • Emulate Inc.
    • InSphero AG
    • Mimetas B.V.
    • Nortis, Inc.
    • Organovo Holdings, Inc.
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Top Player Positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increasing Prevalence of Cancer
3.5.1.2.Rising Demand for Personalized Medicine

3.5.2.Restraints

3.5.2.1.Complexity of organ-tumor-on-a-chip
3.5.2.2.Incompatibility of currently used material in manufacturing chip

3.5.3.Opportunity

3.5.3.1.Novel Techniques in oncology research

3.6.Impact Analysis of COVID-19 on the Organ-tumor-on-a-chip Market

CHAPTER 4:ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Lung Tumor-on-a-Chip

4.2.1.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Bone Marrow Tumor-on-a-chip

4.3.1.Market size and forecast
4.3.2.Market analysis, by country

4.4.Brain Tumor-on-a-chip

4.4.1.Market size and forecast
4.4.2.Market analysis, by country

4.5.Breast Tumor-on-a-chip

4.5.1.Market size and forecast
4.5.2.Market analysis, by country

4.6.Urinary System Tumor-on-a-chip

4.6.1.Market size and forecast
4.6.2.Market analysis, by country

4.7.Intestine Tumor-on-a-chip

4.7.1.Market size and forecast
4.7.2.Market analysis, by country

4.8.Liver Tumor-on-a-chip

4.8.1.Market size and forecast
4.8.2.Market analysis, by country

CHAPTER 5:ORGAN-TUMOR-ON-A-CHIP, BY REGION

5.1.Overview

5.1.1.Market size and forecast

5.2.North America

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by country

5.2.2.1.U.S. organ-tumor-on-a-chip market, by Type
5.2.2.2.Canada organ-tumor-on-a-chip market, by type
5.2.2.3.Mexico organ-tumor-on-a-chip market, by type

5.2.3.North America market size and forecast, by type

5.3.Europe

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by country

5.3.2.1.Germany organ-tumor-on-a-chip market, by type
5.3.2.2.France organ-tumor-on-a-chip market, by type
5.3.2.4.UK organ-tumor-on-a-chip market, by type
5.3.2.5.Italy organ-tumor-on-a-chip market, by type
5.3.2.7.Spain organ-tumor-on-a-chip market, by type
5.3.2.8.Rest of Europe organ-tumor-on-a-chip market, by type

5.3.3.Europe market size and forecast, by type

5.4.Asia-Pacific

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by country

5.4.2.1.Japan organ-tumor-on-a-chip market, by type
5.4.2.2.China organ-tumor-on-a-chip market, by type
5.4.2.3.Australia organ-tumor-on-a-chip market, by type
5.4.2.5.India organ-tumor-on-a-chip market, by type
5.4.2.6.South Korea organ-tumor-on-a-chip market, by type
5.4.2.7.Rest of Asia-Pacific organ-tumor-on-a-chip market, by type

5.4.3.Asia-Pacific market size and forecast, by type

5.5.LAMEA

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by country

5.5.2.1.Brazil organ-tumor-on-a-chip market, by type
5.5.2.2.Saudi Arabia organ-tumor-on-a-chip market, by type
5.5.2.3.South Africa organ-tumor-on-a-chip market, by type
5.5.2.4.Rest of LAMEA organ-tumor-on-a-chip market, by type

5.5.3.LAMEA market size and forecast, by type

CHAPTER 6:COMPANY PROFILES

6.1.AXOSIM TECHNOLOGIES LLC

6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Product portfolio
6.1.5.Key strategic moves and development

6.2.BEONCHIP S.L.

6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Product portfolio

6.3.BIOIVT LLC

6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio
6.3.5.Key strategic moves and development

6.4.EMULATE INC.

6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Product portfolio

6.5.INSPHERO AG

6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.5.4.Product Portfolio

6.6.MIMETAS B.V.

6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Product portfolio
6.6.5.Key strategic moves and development

6.7.NORTIS, INC.

6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio

6.8.ORGANOVO HOLDINGS, INC.

6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Operating business segments
6.8.4.Product portfolio
6.8.5.Business performance

LIST OF TABLES

TABLE 01.ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020–2030 ($THOUSAND)
TABLE 02.ORGAN-TUMOR-ON-A-CHIP MARKET FOR LUNG TUMOR-ON-A-CHIP, BY REGION, 2020–2030 ($THOUSAND)
TABLE 03.ORGAN-TUMOR-ON-A-CHIP MARKET FOR BONE MARROW TUMOR-ON-A-CHIP, BY REGION, 2020–2030 ($THOUSAND)
TABLE 04.ORGAN-TUMOR-ON-A-CHIP MARKET FOR BRAIN TUMOR-ON-A-CHIP, BY REGION, 2020–2030 ($THOUSAND)
TABLE 05.ORGAN-TUMOR-ON-A-CHIP MARKET FOR BREAST TUMOR-ON-A-CHIP, BY REGION, 2020–2030 ($THOUSAND)
TABLE 06.ORGAN-TUMOR-ON-A-CHIP MARKET FOR URINARY SYSTEM TUMOR-ON-A-CHIP, BY REGION, 2020–2030 ($THOUSAND)
TABLE 07.ORGAN-TUMOR-ON-A-CHIP MARKET FOR INTESTINE TUMOR-ON-A-CHIP, BY REGION, 2020–2030 ($THOUSAND)
TABLE 08.ORGAN-TUMOR-ON-A-CHIP MARKET FOR LIVER TUMOR-ON-A-CHIP, BY REGION, 2020–2030 ($THOUSAND)
TABLE 09.ORGAN-TUMOR-ON-A-CHIP MARKET, BY REGION, 2020-2030 ($THOUSAND)
TABLE 10.NORTH AMERICA ORGAN-TUMOR-ON-A-CHIP MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 11.U.S. ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 12.CANADA ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 13.MEXICO ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 14.NORTH AMERICA ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 15.EUROPE ORGAN-TUMOR-ON-A-CHIP MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 16.GERMANY ORGAN-TUMOR-ON-A-CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($THOUSAND)
TABLE 17.FRANCE ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 18.UK ORGAN-TUMOR-ON-A-CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($THOUSAND)
TABLE 19.ITALY ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 20.SPAIN ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 21.REST OF EUROPE ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 22.EUROPE ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 23.ASIA-PACIFIC ORGAN-TUMOR-ON-A-CHIP MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 24.JAPAN ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 25.CHINA ORGAN-TUMOR-ON-A-CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($THOUSAND)
TABLE 26.AUSTRALIA ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 27.INDIA ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 28.SOUTH KOREA ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 29.REST OF ASIA-PACIFIC ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 30.ASIA-PACIFIC ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 31.LAMEA ORGAN-TUMOR-ON-A-CHIP MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 32.BRAZIL ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 33.SAUDI ARABIA ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 34.SOUTH AFRICA ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 35.REST OF LAMEA ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 36.LAMEA ORGAN-TUMOR-ON-A-CHIP MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 37.AXOSIM: COMPANY SNAPSHOT
TABLE 38.AXOSIM: PRODUCT PORTFOLIO
TABLE 39.AXOSIM: KEY DEVELOPMENTS
TABLE 40.BEONCHIP: COMPANY SNAPSHOT
TABLE 41.BEONCHIP: PRODUCT PORTFOLIO
TABLE 42.BIOIVT: COMPANY SNAPSHOT
TABLE 43.BIOIVT: PRODUCT PORTFOLIO
TABLE 44.BIOIVT: PRODUCT PORTFOLIO
TABLE 45.BIOIVT: KEY DEVELOPMENTS
TABLE 46.EMULATE, INC: COMPANY SNAPSHOT
TABLE 47.EMULATE: PRODUCT PORTFOLIO
TABLE 48.INSPHERO AG: COMPANY SNAPSHOT
TABLE 49.INSPHERO AG: PORTFOLIO
TABLE 50.MIMETAS: COMPANY SNAPSHOT
TABLE 51.MIMETAS.: PRODUCT PORTFOLIO
TABLE 52.MIMETAS: KEY DEVELOPMENTS
TABLE 53.NORTIS, INC.: COMPANY SNAPSHOT
TABLE 54.NORTIS: PRODUCT PORTFOLIO
TABLE 55.ORGANOVO HOLDINGS: COMPANY SNAPSHOT
TABLE 56.ORGANOVO HOLDINGS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.ORGAN-TUMOR-ON-A-CHIP MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS IN ORGAN-TUMOR-ON-A-CHIP MARKET
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*
FIGURE 06.HIGH BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.MODERATE THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.MARKET DYNAMICS: ORGAN-TUMOR-ON-A-CHIP MARKET
FIGURE 13.COMPARATIVE ANALYSIS OF ORGAN-TUMOR-ON-A-CHIP MARKET FOR LUNG TUMOR-ON-A-CHIP, BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF ORGAN-TUMOR-ON-A-CHIP MARKET FOR BONE MARROW TUMOR-ON-A-CHIP, BY COUNTRY, 2020 & 2030 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF ORGAN-TUMOR-ON-A-CHIP MARKET FOR BRAIN TUMOR-ON-A-CHIP, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF ORGAN-TUMOR-ON-A-CHIP MARKET FOR BREAST TUMOR-ON-A-CHIP, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF ORGAN-TUMOR-ON-A-CHIP MARKET FOR URINARY SYSTEM TUMOR-ON-A-CHIP,  BY COUNTRY, 2020 & 2030 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF ORGAN-TUMOR-ON-A-CHIP MARKET FOR INTESTINE TUMOR-ON-A-CHIP, BY COUNTRY, 2020 & 2030 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF ORGAN-TUMOR-ON-A-CHIP MARKET FOR LIVER TUMOR-ON-A-CHIP, BY COUNTRY, 2020 & 2030 (%)
FIGURE 20.ORGANOVO HOLDINGS: NET SALES, 2018–2020 ($MILLION)


 
 

This section provides opinions of the top-level CXOs in the organ-tumor-on-a-chip industry. According to CXOs, of leading companies in the market, it has been estimated that the increasing global burden of cancer has significantly mounted over the past decade. As tumor chips can simulate the 3D microstructure and microphysiological functions of in vivo human organs/tissues, providing a better understanding of the mechanisms of tumor growth and metastasis. Thus, the increasing prevalence of cancer is anticipated to support the growth of the organ-tumor-on-a-chip market during the forecast period.

On the contrary, complexity of organ-tumor-on-chip due to esoteric microfabrication technologies makes it difficult to simulate the various complex signal regulation responses of other nonadjacent organs in the human body to cancer, which can hamper the market growth during the forecast period

North America is expected to account for the highest market share in 2020, owing to the rise in demand for organ-tumor-on-chips in drug screening, especially in the U.S., increase in number of key market players, and research centers in the region.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. Organ-tumor-on-a-chip is a miniature cell culture device that simulates tumor cell tissue structure and functional units in vitro

A. The total market value of organ-tumor-on-a-chip market is $5,937.27 thousand in 2020

A. The market value of organ-tumor-on-a-chip market in 2030 is $117,471.41 thousand

A. Tumor-on-a-chip can be used to simulate tumor growth and expansion, angiogenesis, and progression from early to advanced lesions involving epithelial–mesenchymal transition (EMT), tumor cell invasion and metastasis.

A. BioIVT LLC, Beonchip S.L, Organovo Holdings, Inc held a high market postion owing to the strong geographical foothold in different regions.

A. Lung tumor-on-a-chip segment dominates the global market, and is anticipated to continue this trend during the forecast period owing to rising prevalence in lung cancer cases.

A. The major Factors that drive the organ-tumor-on-a-chip market include rise in prevalence of cancer and surge in demand for personalized medicine globally. Furthermore, cheaper availability of organ-tumor-on-a-chip can boost the market growth.

A. Owing to increase in prevalence of cancer and demand for personalized medicine because the personalized medicine technology provide accurate results for selection of right treatment therapy.

A. The forcast period for organ-tumor-on-a-chip market is 2021 to 2030

A. The base year is 2020 in organ-tumor-on-a-chip market

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Organ-tumor-on-a-chip Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers